Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TRAILR1/TNFRSF10A Antibody (HS101) - BSA Free, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP280064

Catalog No. NB013192


Only null left
Add to Cart

Description

Description

TRAILR1/TNFRSF10A Monoclonal specifically detects TRAILR1/TNFRSF10A in Human samples. It is validated for Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Block/Neutralize.
Specifications

Specifications

TRAILR1/TNFRSF10A
Monoclonal
1 mg/mL
Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Block/Neutralize
APO2, CD261, CD261 antigen, cytotoxic TRAIL receptor, Death receptor 4, DR4, DR4 TRAIL receptor 1, TNF-related apoptosis inducing ligand receptor 1, TNF-related apoptosis-inducing ligand receptor 1, TRAIL-R1, TRAILR-1, TRAILR1MGC9365, tumor necrosis factor receptor superfamily member 10A, tumor necrosis factor receptor superfamily, member 10a
Mouse
Protein G purified
RUO
Primary
Recognizes human TRAILR1/TNFRSF10A. Does not cross-react with human TRAIL-R2, -R3 or -R4.
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG1
Flow Cytometry, Immunofluorescence, Immunoprecipitation, Blocking Assay
HS101
Unconjugated
PBS containing 10% glycerol
TNFRSF10A
Recombinant human TRAILR1/TNFRSF10A (DR4).
100 μg
Apoptosis, Cancer
8797
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.